Elixinol Wellness voluntary suspension request

Elixinol Wellness Limited (ASX:EXL) has requested an immediate suspension from quotation under Listing Rule 17.2, pending the release of an announcement about a capital raising and corporate transaction. The suspension is anticipated to remain in place until the company makes an announcement to the market regarding the permitted purpose, which is expected to occur on Thursday, 3 October 2024.

Executive Commentary on Voluntary Suspension

The voluntary suspension from quotation is a strategic move by Elixinol Wellness Limited to facilitate the forthcoming announcement of a capital raising and corporate transaction. The company is committed to providing timely and transparent information to the market, and this suspension aligns with that commitment. We anticipate that the forthcoming announcement will provide clarity and insight into our strategic initiatives and the potential impact on our corporate structure.

Summary of Elixinol Wellness Suspension Request

Elixinol Wellness Limited (ASX:EXL) has voluntarily requested a suspension from quotation in anticipation of an upcoming announcement related to a capital raising and corporate transaction. The company aims to keep the market informed and plans to provide further details on Thursday, 3 October 2024. This proactive approach demonstrates the company's dedication to transparent communication and strategic decision-making. Investors and stakeholders can look forward to the forthcoming announcement for insights into Elixinol Wellness' future corporate direction and potential opportunities.